Emergent BioSolutions Inc. (EBS)

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives, Antibody Therapeutics, Devices, and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Address

300 PROFESSIONAL DR
GAITHERSBURG, MD 20879

Founded

1998

Number of Employees

1,600

Website

http://www.emergentbiosolutions.com

Buyback

Buyback Data 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
$ Amount Purchased
($ in 000s )		 $200 $100 - $83 - - - $112,423 $75,447 - - $37,651
Average Price $27.64 $37.87 - $30.63 - - - $42.67 $42.34 - - $42.50
# Shares Purchased 7,236 2,641 - 2,719 - - - 2,634,798 1,781,868 - - 885,852
Buyback Performance 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
Total Return to Date -74.7% -81.5% - -77.1% - - - -83.6% -83.5% - - -83.5%
S&P 500 Return to Date 181.9% 173.0% - 129.7% - - - 31.7% 37.3% - - 110.7%
Excess Total Return -256.5% -254.5% - -206.9% - - - -115.2% -120.7% - - -194.2%
Quartile Rank
Percentile Rank 9% 6% - 6% - - - 3% 3% - - 4%
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)

People also followed
KRAMER ROBERT

Emergent BioSolutions Inc.
ALNYLAM PHARMACEUTICALS, INC.

Regulus Therapeutics Inc.
SIGA TECHNOLOGIES INC
ABDUN-NABI DANIEL

Emergent BioSolutions Inc.